TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

INNOPHARMA

OncologyGastroenterology
Generics

INNOPHARMA is a generic drug manufacturer focused on Oncology, Gastroenterology.

2020
Since
1
Drugs
-
Trials
5
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 70%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Gastroenterology 30%
0 drugs Phase 2: 1 Phase 1: 1

Pipeline Strength Pro

Loading...